TADALAFIL | A209250 | UNICHEM LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ELI LILLY AND COMPANY et al v. UNICHEM LABORATORIES LIMITED et al 1 patentANDA 209250tadalafil | D.N.J. | 2017-12-19 | Terminated 2018-05-11 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1721
per ea
Lowest NADAC/Unit
$0.1031
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 29300028905TADALAFIL 20 MG TABLET | $0.1721 | EA | Generic | — | 2026-06-17 |
| 29300028913TADALAFIL 20 MG TABLET | $0.1721 | EA | Generic | — | 2026-06-17 |
| 29300028805TADALAFIL 10 MG TABLET | $0.1673 | EA | Generic | — | 2026-06-17 |
| 29300028813TADALAFIL 10 MG TABLET | $0.1673 | EA | Generic | — | 2026-06-17 |
| 29300028605TADALAFIL 2.5 MG TABLET | $0.1156 | EA | Generic | — | 2026-06-17 |
| 29300028613TADALAFIL 2.5 MG TABLET | $0.1156 | EA | Generic | — | 2026-06-17 |
| 29300028705TADALAFIL 5 MG TABLET | $0.1031 | EA | Generic | — | 2026-06-17 |
| 29300028713TADALAFIL 5 MG TABLET | $0.1031 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.